We present here a large Israeli-Arab kindred with hereditary deafness. In this family 55 deaf subjects (29M, 26F), who are otherwise healthy, have been identified and traced back five generations to one common female ancestor. The deafness is progressive in nature, usually presenting in infancy and childhood. Audiometry on six deaf and seven unaffected subjects was consistent with severe to profound sensorineural hearing loss. Based on formal family segregation analysis, the inheritance of deafness in this family closely fits the expectation of a two locus model owing to the simultaneous mutation of a mitochondrial gene and an autosomal recessive gene. Thus, this disorder appears to have the unusual features of being an inherited tissue specific mitochondrial disease and apparently requiring the homozygous presence of a nuclear gene for clinical expression. Most importantly, this disorder presents a unique opportunity to investigate the molecular basis of hereditary non-syndromic deafness and normal hearing.
Estimates of the number of gene loci involved in autosomal recessive deafness range from five to thousands, and additional genes must be involved in autosomal dominant and X linked deafness. 45 The molecular basis for several syndromic forms of deafness have recently been linked to specific chromosomal areas,6'0 and in the case of some forms of Alport syndrome the defect has been localised to the type IV collagen a5 chain gene. [11] [12] [13] We present here a large Israeli-Arab kindred with hereditary cochlear non-syndromic deafness, whose family aggregation is most consistent with a two locus mode of inheritance, one locus being mitochondrial and the other being autosomal recessive. This family provides for the first time the opportunity to elucidate the molecular basis leading to at least one kind of non-syndromic deafness.
Subjects and methods
The figure depicts the complete pedigree of this large kindred with deafness. All the family members live in an Israeli-Arab village 10 miles from Tel-Aviv. The proband had apparent hearing ability during the first year of life which allowed her to gain early speech skills. However, after the first year she experienced progressive hearing loss. Audiometric evaluation at 28 years showed profound deafness. Eight of her nine sibs as well as her mother were similarly affected. Subsequently, information regarding the rest of the members of this kindred was sought.
The pedigree data were collected through the various nuclear families that comprise this kindred. Information on affected subjects was always confirmed from first degree relatives. Fifty-five subjects were found to be affected. Most of them had no history of any hearing ability at any age; several, however, developed progressive hearing loss only after a few years of age, which allowed them to acquire lingual speech. Two subjects had normal hearing until adult age with no obvious cause for their late onset deafness (figure).
Six deaf and seven unaffected pedigree members underwent pure tone audiometry between 250 and 8000 Hz, and ipsilateral and contralateral acoustic reflex measurements. Eight deaf subjects were examined in detail by history, physical examination, and basic laboratory tests such as blood counts and chemistries.
The familial segregation was initially analysed for mendelian genetic inheritance patterns by standard segregation analysis. ' Israeli-Arab pedigree with sensorineural deafness. 
Discussion
In the large Israeli-Arab kindred presented here, progressive sensorineural deafness was most likely to be caused by the simultaneous inheritance of a mitochondrial mutation and an autosomal recessive mutation. This is based both on the rejection of alternative models, and the excellent fit between the model and the observed family segregation in the aggregate and within individual nuclear sibships. Heteroplasmy of the mitochondrial mutation is the second most likely explanation for the deafness aggregation in this family. Although most mitochondrial deletion mutations leading to disease are heteroplasmic, several lines of evidence, in addition to the molecular studies to date, make mitochondrial inheritance with heteroplasmy unlikely in this pedigree. Most importantly, the clinical phenotype is relatively homogeneous within each family, between families, and between generations, with most subjects developing deafness in infancy or early childhood, making a dose effect less likely. In addition, there are only very few descriptions of a stable passage of heteroplasmic mitochondrial DNA from one generation to the next,2224 heteroplasmy is virtually absent in the general population despite a high mitochondrial mutation rate,292' and in vitro injections of mitochondria into cells lead to rapid replacement of endogenous mitochondrial DNA.28 Nevertheless, the final answer regarding heteroplasmy must await the molecular identification of the mitochondrial mutation.
The high frequency of the autosomal gene could be explained in three possible ways. First, it could be a common polymorphism in one of the nuclear encoded oxidative phosphorylation subunits, which leads to disease only in association with the special mitochondrial genotype in this family. Second, it could be the result of a high frequency of consanguineous matings, and, third, because of a founder effect in our study population. It is common among Israeli-Arabs who live in the villages to prefer consanguineous marriages, particularly among first cousins. In addition, such villages are often populated by a few (<20) original families. However, consanguineous marriages in the Israeli-Arab community are usually through the paternal side, with the goal of conserving the lands within the family, and thus cannot explain the maternal transmission observed in this family.
The tissue specificity of this disease is intriguing. The mitochondrial genome codes for 13 of the approximately 70 subunits engaged in oxidative phosphorylation, and oxidative phosphorylation is ubiquitous in all nucleated human cells. Most inherited mitochondrial disorders affect a number of tissues, and in particular those with the highest energy requirements such as striated muscle and nerves.2930 However, LHON is mainly limited to the optic nerve, and has recently been shown to be a two locus disease with one mitochondrial point mutation and one locus linked to DXS7 on the X chromosome.31-33 It is possible to speculate, both for LHON and our deafness pedigree, that a mutation affects a tissue specific isoform of a nuclear encoded oxidative phosphorylation subunit, which interacts with the mutated mitochondrial encoded subunit, and leads to tissue specific disease. Although such isoforms have not been reported in humans, they have been described in other species.34 Alternatively, it is possible that the mutated mitochondrial subunit functions normally in oxidative phosphorylation in our pedigree, but interacts abnormally with a hearing specific protein encoded by the nuclear locus.
Our pedigree presents a unique opportunity to investigate for the first time the molecular basis of non-syndromic deafness. The mitochondrial mutation can be identified because of the small size of the mitochondrial chromosome,35 and identification of the autosomal locus is greatly simplified by the power of linkage analysis in this large kindred and the likely interaction between the mitochondrially encoded and autosomally encoded proteins.
Other mitochondrial DNA defects can lead to deafness, as evidenced by the recent description of 22 pedigrees with deafness caused by mitochondrial transmitted susceptibility to aminoglycosides.36 It is possible that the mitochondrial DNA mutation in these cases is similar to the one in our pedigree, and that the phenotypic expression can be induced either by an autosomal recessive mutation or by the aminoglycosides. It can also be speculated that one of the common forms of acquired hearing loss, strial presbyacusis, in which decreased oxidative phosphorylation activity in the stria vascularis has been documented,37 is related to mitochondrial DNA degeneration with age.3839
These data suggest that the molecular study of mitochondrial organelles will lead to an elucidation of biochemical pathways involved in hearing and hearing deficits.
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